GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » Debt-to-Asset

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Debt-to-Asset : 0.21 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co Debt-to-Asset?

Chunghwa Chemical Synthesis & Biotech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$305 Mil. Chunghwa Chemical Synthesis & Biotech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$705 Mil. Chunghwa Chemical Synthesis & Biotech Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was NT$4,867 Mil. Chunghwa Chemical Synthesis & Biotech Co's debt to asset for the quarter that ended in Sep. 2024 was 0.21.


Chunghwa Chemical Synthesis & Biotech Co Debt-to-Asset Historical Data

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chunghwa Chemical Synthesis & Biotech Co Debt-to-Asset Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 - 0.17 0.13 0.23

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.25 0.20 0.21

Competitive Comparison of Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset falls into.



Chunghwa Chemical Synthesis & Biotech Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(504.645 + 704.468) / 5171.651
=0.23

Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(305.015 + 704.519) / 4866.909
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Chunghwa Chemical Synthesis & Biotech Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Chunghwa Chemical Synthesis & Biotech Co Headlines

No Headlines